GFI-Item5-CPP_Phase_2_Protocol-Dated_10Feb2018_Pages_1-40.pdf
PDF 1 MB Posted
- Attached to
- Cryopreserved Platelet (CPP) Development for U. S. Food and Drug Administration Licensure
- Solicitation number
- W81XWH19R0033
- Issued by
-
Department of the Army Medical Command
About this file
Solicitation W81XWH19R0033 Government Furnished Information - Item 5 CPP Phase 2 Protocol Part 1 of 2
View the file
Other files
Show all 14
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Ad Hoc
Contamination of apheresis platelets
Leukoreduction during apheresis platelet collection.
Transfusion of blood components
Unintended thrombosis and thrombotic events associated with increased levels of pro-coagulation parameters associated with platelet cryopreservation sis and thromboticis and thrombotic parameters associaarameters associa ad hoc
File details come from the government source that posted it.